title: Occurrence of MRSA endocarditis during linezolid treatment.
authors.affiliation: Department of General Intensive Care, University Hospital, Domaine universitaire du Sart-Tilman, 4000 Liege, Belgium.
authors.forename: E H
authors.initials: EH
authors.lastname: Ben Mansour
authors.forename: E
authors.initials: E
authors.lastname: Jacob
authors.forename: M
authors.initials: M
authors.lastname: Monchi
authors.forename: D
authors.initials: D
authors.lastname: Ledoux
authors.forename: J-L
authors.initials: JL
authors.lastname: Canivet
authors.forename: P
authors.initials: P
authors.lastname: De Mol
authors.forename: P
authors.initials: P
authors.lastname: Damas
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000150:complications / Q000188:drug therapy*; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000627:therapeutic use*; D018570:Risk Assessment; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid